KADATRUS

GlaxoSmithKline LLC

Application Filed: 2011-08-16

Trademark Application Details

Status

602

Dead/Abandoned

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

Research	OneLook Acronym Finder
Serial Number	85399267
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Diane Fry Maginnis
Attorney Docket Number	TMID/5079452
Law Office Assigned	L20
Employee Name	GARTNER, JOHN M

Timeline

2011-08-16	Application Filed
2013-01-23	Abandon
2013-02-14	Location: TMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED
2013-02-14	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	GlaxoSmithKline LLC
Address	Corporation Service Company 2711 Centerville Road, Suite 400 Wilmington DE 19808
Legal Entity Type	Limited Liability Company
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

DIANE FRY MAGINNIS
GLAXOSMITHKLINE
5 MOORE DR
RESEARCH TRIANGLE PARK, NC 27709-0183

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Type Code

Type

GS0051

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2011-08-19	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2011-08-19	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2011-12-07	3 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN	2011-12-07	4 CNRT R:Renewal
NON-FINAL ACTION E-MAILED	2011-12-07	5 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2011-12-07	6 GNRN O:Outgoing Correspondence
TEAS CHANGE OF OWNER ADDRESS RECEIVED	2012-01-05	7 COAR I:Incoming Correspondence
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED	2012-01-05	8 CHAN I:Incoming Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2012-03-05	9 TROA I:Incoming Correspondence
ASSIGNED TO LIE	2012-03-20	10 ALIE A:Allowance for Publication
CORRESPONDENCE RECEIVED IN LAW OFFICE	2012-03-28	11 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED	2012-03-28	12 TEME I:Incoming Correspondence
NON-FINAL ACTION WRITTEN	2012-04-05	13 CNRT R:Renewal
NON-FINAL ACTION E-MAILED	2012-04-05	14 GNRT O:Outgoing Correspondence
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2012-04-05	15 GNRN O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2012-07-11	16 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2012-07-11	17 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED	2012-07-12	18 TEME I:Incoming Correspondence
FINAL REFUSAL WRITTEN	2012-07-19	19 CNFR R:Renewal
FINAL REFUSAL E-MAILED	2012-07-19	20 GNFR O:Outgoing Correspondence
NOTIFICATION OF FINAL REFUSAL EMAILED	2012-07-19	21 GNFN O:Outgoing Correspondence
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE	2013-02-14	22 ABN2 O:Outgoing Correspondence
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND	2013-02-14	23 MAB2 O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.